A study of a new AI model examining 30 years of routine electronic health records (EHR) data could improve screening for primary aldosteronism, a leading cause of high blood pressure that is often unrecognized but increases patients' risk of cardiovascular complications, according to a study presented at ENDO 2026, the Endocrine Society's annual meeting in Chicago.
People with an organ transplant who develop or have existing diabetes are more likely to die than those without diabetes, according to a comprehensive analysis of solid-organ transplant recipients presented at ENDO 2026, the Endocrine Society's annual meeting in Chicago.
A study led by the Innovation in Vesicles and Cells for Application in Therapy (IVECAT) group at the Germans Trias i Pujol Research Institute (IGTP) has identified a key mechanism regulating the anti-inflammatory function of extracellular vesicles derived from mesenchymal stromal cells. The findings, published in the Journal of Extracellular Vesicles, provide new insights into the therapeutic potential of these vesicles in inflammatory diseases and ischemic processes.
For those scared of needles but who need GLP-1 receptor agonists to help manage their weight, there might be some good news. Researchers are testing a new oral, small-molecule GLP-1 receptor agonist called Elecoglipron, which could offer the weight-loss benefits of GLP-1 therapy without injections.
In a study exploring how an AI-assisted diagnostic tool shaped care for underserved populations at multiple community-based primary care sites, investigators at the Wilmer Eye Institute, Johns Hopkins Medicine, found that African American patients with diabetes were more likely to receive a diabetic eye exam referral if screened by an AI tool.
A straightforward blood-based assessment developed at the Institute of Science Tokyo, Japan, can help assess how effectively high-density lipoprotein (HDL) removes cholesterol from blood vessel walls, a function known as cholesterol efflux capacity (CEC). The study linked low CEC to high-risk coronary plaque, supporting the broader clinical use of this method for predicting cardiovascular risk and improving preventive strategies.
A study of 2,044 older Japanese adults found that those with lower vitamin C levels in their blood plasma tended to have a lower volume of gray matter in their brains, as well as lower connectivity among a collection of brain regions known as the default mode network. Haruka Nagaya of Hirosaki University, Japan, and colleagues present these findings in PLOS One.
Modern breast cancer screening and treatment have transformed survival. Many women now live long and healthy lives after diagnosis, thanks to increasingly effective chemotherapy and targeted therapies: medicines designed to attack particular features of cancer cells.
Only a small number of men who were prescribed testosterone therapy received appropriate, guideline-concordant diagnostic testing, according to a study presented at ENDO 2026, the Endocrine Society's annual meeting in Chicago, by Sophia Sinha, M.D., clinical assistant professor at the University of Michigan in Ann Arbor, Michigan.
The incidence of type 1 diabetes among teens in Puerto Rico more than doubled from 2009 to 2021 and remained elevated through 2024, with an average annual increase of 4.1%, according to a study presented at ENDO 2026, the Endocrine Society's annual meeting in Chicago.
Longer lifetime exposure to female hormones may increase the risk of thyroid cancer in women, according to a study presented at ENDO 2026, the Endocrine Society's annual meeting in Chicago. The research suggests reproductive and hormonal factors may be involved in thyroid carcinogenesis.
People with Alzheimer's disease who took the common supplement glucosamine were 25% more likely to die within five years than those who didn't. That's the key finding of a new study that my colleagues and I published in the journal Nature Metabolism.
Testosterone treatment may improve body composition, glucose metabolism and sexual desire in some older men at high risk of type 2 diabetes (T2D), but the benefits require engagement in a lifestyle program, according to a study presented at ENDO 2026, the Endocrine Society's annual meeting in Chicago.
Male rats exposed to the widely used plasticizer di-(2-ethylhexyl) phthalate (DEHP) during early development exhibited increased anxiety behavior as adults, according to a study presented at ENDO 2026, the Endocrine Society's annual meeting in Chicago.
Endocrine-disrupting chemicals (EDCs) that interfere with hormones were found in breast milk and in the urine of children from birth up to 6 months, according to a study presented at ENDO 2026, the Endocrine Society's annual meeting in Chicago.
---- End of list Med Xpress News Articles on this page 2 of 2 total pages ----